Evidence map›Paper›PMID 40627405›Full record

ArticleEnvironmental toxicology and chemistry2025

Adverse Outcome Pathway (AOP) Coaching Program-how it functions and contributes to a more harmonized approach to AOP development and construction of AOP networks with regulatory utility.

Shihori Tanabe, Tanja Burgdorf, Judy Choi, Nathalie Delrue, Stephen W Edwards, Julija Filipovska, Rex FitzGerald, Sabina Halappanavar, Virginia K Hench, Travis Karschnik and 18 more

Abstract read
In one paragraph

Article in Environmental toxicology and chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Shihori TanabeDivision of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, Kawasaki, Japan.ORCID 0000-0003-3706-0616
Tanja BurgdorfDepartment Experimental Toxicology and ZEBET, Federal Institute for Risk Assessment, Berlin, Germany.
Judy ChoiDepartment of Pesticides Safety, Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Nathalie DelrueOrganisation for Economic Co-operation and Development, Environment Health and Safety Division, Environment Directorate, Paris, France.
Stephen W EdwardsCenter for Computational Toxicology and Exposure, United States Environmental Protection Agency, Research Triangle Park, NC, United States.
Julija FilipovskaIndependent, Ohrid, North Macedonia.
Rex FitzGeraldUniversity of Basel, Basel, Switzerland.
Sabina HalappanavarEnvironmental Health Science and Research Bureau, Ottawa, ON, Canada.
Virginia K HenchOpen BioData Modeling, LLC, Raleigh, NC, United States.
Travis KarschnikGreat Lakes Toxicology and Ecology Division, United States Environmental Protection Agency, Duluth, MN, United States.
Carlie LaLoneGreat Lakes Toxicology and Ecology Division, United States Environmental Protection Agency, Duluth, MN, United States.
Brigitte LandesmannEuropean Commission, Joint Research Centre, Ispra, Italy.
Cinzia La RoccaCenter for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.
Mirjam LuijtenCentre for Health Protection, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
Bette MeekSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
Jason M O'BrienWildlife Toxicology Research Section, Environment and Climate Change Canada, Toronto, ON, Canada.
Edward J PerkinsU.S. Army Engineer Research and Development Center, Environmental Laboratory, Vicksburg, MS, United States.
Magdalini SachanaOrganisation for Economic Co-operation and Development, Environment Health and Safety Division, Environment Directorate, Paris, France.
Stefan ScholzDepartment Ecotoxicology, Helmholtz Centre for Environmental Research, Leipzig, Germany.
You SongNorwegian Institute for Water Research (NIVA), Oslo, Norway.ORCID 0000-0001-8523-3513
Olga TcheremenskaiaEnvironment and Health Department, Istituto Superiore di Sanità (ISS), Rome, Italy.
Russell ThomasCenter for Computational Toxicology and Exposure, United States Environmental Protection Agency, Research Triangle Park, NC, United States.
Knut Erik TollefsenNorwegian Institute for Water Research (NIVA), Oslo, Norway.
Daniel L VilleneuveGreat Lakes Toxicology and Ecology Division, United States Environmental Protection Agency, Duluth, MN, United States.
Barbara VivianiDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy.
Maurice WhelanEuropean Commission, Joint Research Centre, Ispra, Italy.
Clemens WittwehrEuropean Commission, Joint Research Centre, Ispra, Italy.ORCID 0000-0003-2760-7702
Carole YaukDepartment of Biology, University of Ottawa, Ottawa, ON, Canada.ORCID 0000-0002-6725-3454

Funding

Intramural EPA EPA999999Japan Agency for Medical Research and Development JP21mk0101216Japan Agency for Medical Research and Development JP22mk0101216Japan Agency for Medical Research and Development JP23mk0101216Japan Society for the Promotion of Science(JSPS) KAKENHI 21K12133
6 · The paper itself

Abstract

The adverse outcome pathway (AOP) framework contributes to understanding how specific and measurable biological perturbations cause adverse effects on human and environmental health. Recognizing the value of AOPs to support regulatory decisions around the world, the Organisation for Economic Co-operation and Development (OECD) launched the AOP Programme in 2012, which sought to promote and guide the development of AOPs to ensure their suitability for the downstream applications in the context of regulatory safety assessment. The OECD published the initial guidance on AOP development and assessment in 2013, which has been expanded as practices have evolved and matured. Adverse outcome pathway development requires adherence to specific principles and considerations for identifying and describing key events (KEs) and representing and assessing the weight of evidence for the key event relationships. Ultimately, the structured and consistent application of the principles helps build confidence in the applicability of the knowledge represented in the AOP for decision-making in the regulatory context. To assist new AOP developers, in 2019, the OECD introduced a coaching program. This program primarily aims to pair novices with experienced AOP developers (i.e., coaches). International partnerships in the coaching program contribute to harmonizing and promoting AOP development according to OECD guidance. Coaches have also helped to identify and initiate "gardening" efforts that remove redundant/synonymous KEs in the AOP-Wiki, allowing for improved AOP network creation, promoting the reuse of extensively reviewed KEs, and ensuring the development of high-quality AOPs. The AOP Coaching Program represents the latest international activity to ensure that AOPs are developed in a consistent manner that is designed to enhance their use for supporting public health decisions around the world.

Indexed as

Adverse Outcome PathwaysHumansMentoringOrganisation for Economic Co-Operation and Developmentadverse outcome pathwaycoachhazard/risk assessmentontologyrisk assessment

Identifiers

PMID40627405
PMCPMC12906907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.